info@strategicmarketresearch.com
26, Broadway, Suite 934, New York , 10004
us US: +1-315-636-4233    uk UK: +44-162-237-0614     in IN: +91-826-083-6500
smrlogonew
  • Home
  • About
    • Why SMR
    • Research Methodology
    • Media Coverage
    • Join Our Team
  • Reports
    • Aerospace and Defense
    • Agriculture
    • Automotive
    • Chemicals and Materials
    • Consumer Goods
    • Energy and Power
    • Equipment and Machinery
    • Food and Beverages
    • Healthcare
    • Information and Communication Technology
    • Semiconductor and Electronics
    • Manufacturing and Construction
  • Our Practices
    • Syndicated Research
    • Consulting Services
    • Custom Research
    • Full-time Engagement Model
  • Insights
    • Press Release
    • Blog
  • Contact
Home » Healthcare » Atherectomy Devices Market Global Size & Trends | 2030

Atherectomy Devices Market By Type (Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy), By Application (Peripheral Vascular Applications, Cardiovascular Applications, Neurovascular Applications), By End-User (Hospitals and Surgical Centres, Ambulatory Care Centres, Other End Users), By Geography, Segment revenue estimation, Forecast, 2021-2030

Published On: Apr-2022   |   Base Year: 2021   |   No Of Pages: 135   |   Historical Data: 2017 - 2020   |   Formats: PDF   |   Report ID: 67760273

Industry Report and Statistics (Facts & Figures) - Sales Volume, ASP & Number of Procedure Conducted by Procedure Type, Application & End-User

The global atherectomy devices market will witness a robust CAGR of 7.34%, valued at $1.02 billion in 2021, expected to appreciate and reach $2.01 billion by 2030, confirms Strategic Market Research. North America had the highest industry share of 75.83%. Atherectomy is a method that uses a catheter with a sharp blade on the end that removes plaque from a blood vessel. The patient is first sedated. The surgeon then gently inserts the catheter into the patient’s body, usually in the groin or upper thigh. The catheter is then guided gently through the blood vessels into the heart. Once the catheter is at the required position, dye is injected through the catheter into the coronary arteries. An X-ray is conducted to determine the blocked or narrowed area. The surgeon uses tiny blades or lasers attached to the end of the catheter to remove plaque. A study shows over 190,000 atherectomy procedures are performed yearly in the US. This number is expected to surge owing to the increasing prevalence of atherosclerosis among the masses.

 

Atherectomy Devices Market by Infographic

 

Drivers - Rising Prevalence of Diseases and Geriatric Population, Growing Preference for minimally invasive surgical procedures, and Higher Success Rate

  • The rising prevalence of cardiovascular diseases, the growing geriatric population, and the trend towards minimally invasive treatments drive the atherectomy devices market. Atherosclerosis & other cardiovascular conditions are the leading causes of morbidity & mortality worldwide. UK's 2.6 million people have heart artery narrowing, potentially causing heart attacks or angina. The American Heart Association estimates that 16 Mn Americans have coronary artery disease, the number one killer in the US. The aging population is more exposed to these diseases due to age-related changes in arterial fitness. The growing geriatric population drives the demand for atherectomy devices. Technological advancements in atherectomy devices have made procedures safer and more effective, attracting healthcare providers and physicians to adopt atherectomy procedures. Increasing awareness and diagnostic capabilities contribute to the growing demand for atherectomy procedures, with timely detection and accurate diagnosis of atherosclerotic lesions enabling healthcare providers to recommend appropriate interventions. Overall, these factors contribute to the growing demand for atherectomy procedures as an effective treatment option for atherosclerosis, driving innovation in device development.

 

  • The growing preference for minimally invasive surgical processes is a significant market driver for atherectomy devices. These procedures offer several advantages over traditional open surgeries, such as reduced trauma, faster recovery, lower complication rates & reduced healthcare costs. Patients and healthcare providers appreciate the quicker recovery, reduced postoperative pain, and shorter hospital stays associated with minimally invasive procedures. Technological advancements have also improved the effectiveness and safety of atherectomy procedures, making them more appealing to patients and healthcare providers. Patient-centric care and shared decision-making processes prioritize patient preferences, leading to healthcare providers offering atherectomy procedures and driving the demand for atherectomy devices. As the need for minimally invasive procedures continues to rise, the market for atherectomy devices is expected to grow, with manufacturers investing in R&D to meet the evolving demands of patients & healthcare providers.

 

Restraints - High Costs, High Restenosis Rate

  • Atherectomy devices are specialized medical instruments used to treat atherosclerosis caused by plaque buildup in arteries. These devices are popular due to their minimally invasive nature & potential benefits over traditional treatments like angioplasty. However, the cost of atherectomy devices are high due to research and development, manufacturing and technology, regulatory compliance, limited competition, and physician training and support. These costs can impact healthcare providers and patients, as they may limit their ability to acquire multiple devices or invest in the latest advancements. Additionally, patients may face higher out-of-pocket expenses or increased insurance premiums due to the costly nature of atherectomy devices, limiting access to these procedures. Addressing these cost factors would improve affordability and accessibility, allowing more patients to benefit from this advanced treatment option.

 

  • The high restenosis rate is a significant market restraint for atherectomy devices, as it can lead to re-narrowing or re-occlusion of the treated artery after an atherectomy procedure. This can negatively impact patient health and increase healthcare costs. Additionally, the high restenosis rate may influence market competition among different treatment modalities for atherosclerosis. Atherectomy device manufacturers can improve patient outcomes, enhance reimbursement prospects, and strengthen their market position by addressing restenosis. Ongoing research and technological advancements in this field will play a pivotal role in reducing restenosis and expanding the utilization of atherectomy devices as an effective treatment option for atherosclerosis.

 

Opportunities - Technological Advancements

  • Technological advances significantly contribute to the growth and adoption of atherectomy devices, driving innovation, improving device performance, and enhancing patient outcomes. Improved device design and performance, minimally invasive approaches, combination therapies, imaging and navigation technologies, and the integration of robotics and AI offer reduced patient discomfort, shorter hospital stays, faster recovery times, and lower healthcare costs. Combination therapies, such as angioplasty, stenting & drug delivery systems, offer synergistic benefits in treating atherosclerosis, reducing restenosis risk, and optimizing patient outcomes. Integrating robotics and AI technologies in atherectomy devices provides promising opportunities for improved precision, stability, and control. Technological advancements in the atherectomy devices market provide an opportunity to proliferate the market further.

 

Atherectomy Devices By Share
 

Market Analysis Of Different Segments Covered in the Report

Based on Type

  • Directional Coronary Atherectomy

  • Rotational Atherectomy

  • Orbital Atherectomy

  • Laser Atherectomy

 

Based on Application

  • Peripheral Vascular Applications

  • Cardiovascular Applications

  • Neurovascular Applications

 

Based on End-User

  • Hospitals and Surgical Centres

  • Ambulatory Care Centres

  • Other End Users

Atherectomy Devices Market By Application

 

Regional Coverage Analysis

North America

  • United States of America

  • Canada

  • Mexico

  • Rest of North America

 

Europe

  • United Kingdom

  • Germany

  • France

  • Italy

  • Rest of Europe

 

Asia-Pacific

  • Japan

  • China

  • India

  • Rest of APAC

 

LAMEA

  • Argentina

  • Brazil 

  • UAE

  • Rest of LAMEA

 

Segments Analysis & Insights

Based on type, the orbital atherectomy segment held the largest industry size, with almost 30% in 2020. Orbital atherectomy is an adjunctive technique used for the lesion preparation of calcified plaque. This is done to avoid percutaneous coronary intervention and peripheral percutaneous endovascular interventions. According to a research study published by the American Heart Association, the success rate of orbital atherectomy was 99%.

On the other hand, the laser atherectomy market is expected to grow the fastest with a CAGR of 7% due to its suitability for clinical benefits offered and ongoing increasing developments in directional Atherectomy technology. According to a study, 24% of all atherectomy procedures were done using a laser.

The peripheral vascular applications segment is expected to contribute a significant market share based on application. This segment is expected to register the maximum CAGR of 6.71% due to its attribution to increasing acceptance of atherectomy to treat cardiac and peripheral vascular diseases over the forecasted period.

 

Based on the End-Users, the atherectomy devices market is categorized into hospitals & surgical centres, ambulatory care centres & other end users. The Hospitals and surgical centres dominate the atherectomy devices market with a revenue share of 60%, growing with a CAGR of 6.63%, poised to reach $1.21 Bn by 2030. Hospitals and surgical centres are the primary end-users of atherectomy devices due to their advanced infrastructure, multidisciplinary approach, access to skilled healthcare professionals, availability of resources and support services, involvement in research and education, referral networks, and expertise in reimbursement and insurance coverage. These facilities are critical in diagnosing, treating, and managing cardiovascular diseases, including atherosclerosis, for which atherectomy procedures are performed. Hospitals & surgical centres have many resources and support services, including emergency medical services, blood banks, intensive care units, and specialized recovery units. Their active involvement in research and education drives innovation, refines techniques, and promotes the adoption of atherectomy devices. Overall, hospitals and surgical centres dominate the atherectomy devices market, driving demand and contributing to the growth and development of the market.

 

The North American region had the highest market share of 75.83%. The rising number of cardiovascular, neurovascular, and peripheral diseases, better technology, and more trained medical professionals in atherectomy contributed to the industry's growth. According to the CDC, around 6.5 million people aged 40 and older have peripheral artery disease in the USA. Asia-Pacific is forecasted to have the maximum industry growth from 2020 to 2030, with a CAGR of 8.2%. Socioeconomic changes, unhealthy diet, liquor intake, smoking, and demographic aging have increased target diseases and increased demand for the overall market. According to an NCBI study, 4.77 million Indians will have cardiovascular diseases in 2020.

 

Atherectomy Devices Market Report Coverage

Report Attribute

Details

Forecast Period

2021 - 2030

The market size value in 2021

USD 1.02 billion

The revenue forecast in 2030

USD 2.01 billion

Growth rate

CAGR of approximately 7.34%

The base year for estimation

2021

Historical data

2017 – 2020

Unit

USD Billion, CAGR (2021 - 2030)

Segmentation

By Type, By Application, By End-Use, By   Region

By Type

Directional Atherectomy, Rotational Atherectomy, Orbital Atherectomy, Laser Atherectomy

By Application

Peripheral Vascular Applications, Cardiovascular Applications, Neurovascular Applications

By End-Use

Hospitals and Surgical Centres, Ambulatory Care Centres, Other End Users

By Region

Asia Pacific, North America, Europe, LAMEA

Country Scope

United States of America, Canada, Mexico, United Kingdom, Germany, France, Italy, Japan, India, China, Argentina, Brazil, United Arab Emirates

Company Usability Profiles

Abbott Laboratories, Boston Scientific Corporation, Medtronic, Becton, Dickinson and Company (BD Interventional), Koninklijke Philips N.V., Avinger, Inc., Rex Medical, AngioDynamics

Cost & acquiring options

Get hold of customized purchase options to fulfill your niche research needs.

 

Atherectomy Devices Market Competitive Landscape Analysis

The industry is moderately competitive, with many key players in the market. Some major companies that are currently operating in this market are:

  • Abbott Laboratories

  • Boston Scientific Corporation

  • Medtronic

  • Becton, Dickinson, and Company (BD Interventional)

  • Koninklijke Philips N.V.

  • Avinger, Inc.

  • Rex Medical

  • AngioDynamics

Atherectomy Devices Market Based on Region

Recent Developments

  • On June 2023, Avinger, Inc. received FDA clearance for Pantheris LV, its next-generation image-guided atherectomy system for treating peripheral artery disease (PAD). The system offers new features, including higher cutter speeds, plaque apposition design, and enhanced torque feedback. It will be limitedly launched by the end of the quarter and expand to full commercial availability in the second half of 2023. Avinger's Lumivascular technology uses optical coherence tomography (OCT) images to guide treatment, ensuring safe and effective outcomes without ionizing radiation exposure.

 

  • On February 2023, Abbott acquired Cardiovascular Systems, a prominent medical device company known for its cutting-edge atherectomy system designed to address peripheral & coronary artery disease. Under the terms of the agreement, CSI stockholders will receive a cash consideration of $20/common share, resulting in an anticipated equity value of $890 Mn. CSI is a renowned industry leader in the field of atherectomy devices. These devices are designed to optimize the advantages of standard balloon angioplasty & stent treatments, particularly in cases involving intricate arterial diseases. The acquisition will enhance Abbott's portfolio of vascular devices by incorporating complementary technologies.

 

Various Leading Atherectomy Devices that Key Market Leaders Develop

Name of the Product

Function

Key Player

Auryon Atherectomy System Catheter

Treatment of above-the-knee calcified lesions

AngioDynamics

Pantheris

Image-Guided Atherectomy

Avinger, Inc.

Crosser Catheter S6

Facilitates intraluminal placement of conventional guidewires beyond peripheral artery chronic total occlusions (CTO) via atherectomy

Becton, Dickinson, and Company (BD Interventional)

Turbo-Elite Laser Atherectomy Catheter

Treatment of multiple lesion morphologies within PAD lesions using ultraviolet radiation

Koninklijke Philips NV

Revolutionary Peripheral Atherectomy System

Ablation and removal of thrombus and atherosclerotic plaque from peripheral arteries

Rex Medical, Inc.

 

Frequently Asked Question About This Report

The types of atherectomy are directional, rotational, orbital, and laser atherectomy.

The success rate of atherectomy was found to be greater than 96%.

The global atherectomy devices market is expected to grow at a compound annual growth rate (CAGR) of 7.34% from 2021 to 2030 to reach USD2.01 billion by 2030.

Orbital atherectomy is an adjunctive process used to prepare lesions before percutaneous coronary infection and peripheral percutaneous endovascular intervention.

The global atherectomy devices market size was $1.06 Bn in 2021 and is predicted to reach $2.01 Bn by 2030, with a CAGR of 7.34%.

Atherectomy devices are those devices that are used to remove the thrombus and plaque from a blood vessel.

The laser product segment across the market is witnessing significant expansion because it is found to be suitable for clinical benefits offered and the ongoing increasing developments of directional atherectomy technology.


Sources

https://www.ahajournals.org/doi/10.1161/01.cir.102.21.2593

https://www.healthline.com/health/vitrectomy

https://www.ncbi.nlm.nih.gov/books/NBK557482/

https://www150.statcan.gc.ca/n1/daily-quotidien/220822/dq220822b-eng.htm

https://www.ahajournals.org/doi/10.1161/01.CIR.96.1.128

https://www.dicardiology.com/content/abbott-acquire-cardiovascular-systems-inc

https://finance.yahoo.com/news/avinger-receives-510-k-clearance-120000796.html

https://www.pandct.com/news/high-speed-brushless-motor-enhances-atherectomy-procedures-for-medical-device-manufacturer

https://www.hopkinsmedicine.org/health/conditions-and-diseases/coronary-heart-disease

 

 

 

 

1.  Introduction

    1.1. Study Objective

    1.2. Market Definition   

    1.3. Study Scope

       1.3.1. Markets Covered

       1.3.2. Geographic Scope

       1.3.3. Years Considered

       1.3.4. Stakeholders

2.  Research Methodology

    2.1. Data Procurement

    2.2. Paid Database

       2.2.1. Secondary Data

           2.2.1.1. Key Secondary sources

       2.2.2. Primary Data

  2.2.2.1 Primary sources

           2.2.2.2. Key industry insights

           2.2.2.3. Primary interviews with experts

           2.2.2.4. Key primary respondent list

    2.3. Market Size Estimation

    2.4. Bottom-Up and Top-Down Approaches

       2.4.1.   Bottom-Up Approach

           2.4.1.1.     Approach for arriving at market size by bottom-up analysis

       2.4.2.   Top-Down Approach

           2.4.2.1.     Approach for Capturing Market Size by Top-Down Analysis

    2.5. Market Breakdown and Data Triangulation

    2.6. Research Methodology

    2.7. Risk Assessment

3. Executive Summary

    3.1  Market: Post-Covid-19

       3.1.1   Actual Scenario

       3.1.2   Pessimistic Scenario

       3.1.3   Optimistic Scenario

       3.1.4   Market Summary

4. Industry Outlook

    4.1 Market Snapshot

    4.2 Global Atherectomy Devices Market

       4.2.1   Global market, 2021 – 2030 (USD Million)

    4.3 Regional Business Analysis

       4.3.1   Global market, by Region, 2021-2030 (USD Million)

    4.4 By Type Business Analysis

       4.4.1   Global market, By Type, 2021-2030 (USD Million)

    4.5 By End-User Business Analysis

       4.5.1   Global market, By End-User, 2021-2030 (USD Million)

    4.6 Application Business Analysis

       4.6.1   Global market, By Application, 2021-2030 (USD Million)

    4.7 Value Chain Analysis

    4.8 Market Variable Analysis

       4.8.1   Market Drivers Analysis

       4.8.2   Market Restraints Analysis

    4.9 Business Environment Analysis Tool

       4.9.1    market PEST analysis

       4.9.2    market Porter’s analysis

    4.10Penetration & Growth Prospect Mapping

5. Market Dynamics

    5.1. Introduction

    5.2. Market Dynamics

       5.2.1.   Drivers

       5.2.2.   Restraints

       5.2.3.   Opportunities

       5.2.4.   Challenges

    5.3. Impact of Covid-19 On Market

    5.4. Value Chain Analysis

    5.5. Ecosystem

    5.6. Patent Analysis

    5.7. Trade Analysis

    5.8. Tariff Analysis

    5.9. Case Study Analysis

5.10.   Porter’s Five Forces Analysis

       5.10.1  Threat of New Entrants

       5.10.2  Threat of Substitutes

       5.10.3  Bargaining Power of Buyers

       5.10.4  Bargaining Power of Suppliers

       5.10.5  Degree of Competition

    5.11.       Application Analysis

       5.11.1.  Trends in Application (2014-2020)

       5.11.2.  Trends in Application (2021-2028)

    5.12.       Pricing Analysis

       5.12.1.  Average Price Trend Analysis (By Region, By Countries)

6. Competitive & Vendor Landscape

    6.1. Company Market Share Analysis

    6.2. Manufacturers Manufacturing Sites, Area Served, Product Type

    6.3. Market Competitive Situation and Trends

    6.4. Manufacturers Mergers & Acquisitions, Expansion Plans

7. Global Market: By Type Segment Analysis

    7.1. Introduction

    7.2. Sales Volume & Revenue Analysis (2021-2030)

    7.3. Directional Atherectomy

       7.3.1. Directional Atherectomy market, 2021-2030 (USD Million)

    7.4. Rotational Atherectomy

       7.4.1. Rotational Atherectomy market, 2021-2030 (USD Million)

    7.5. Orbital Atherectomy

       7.5.1. Orbital Atherectomy market, 2021-2030 (USD Million)

    7.6. Laser Atherectomy

       7.6.1. Laser Atherectomy market, 2021-2030 (USD Million)

 

8. Global Market: By End-User Segment Analysis

    8.1. Introduction

    8.2. Sales Volume & Revenue Analysis (2021-2030)

    8.3. Hospitals and Surgical Centres

       8.3.1.   Hospitals and Surgical Centresmarket, 2021-2030 (USD Million)

    8.4. Ambulatory Care Centres

       8.4.1.   Ambulatory Care Centresmarket, 2021-2030 (USD Million)

    8.5. Other End Users

       8.5.1.   Other End Users market, 2021-2030 (USD Million)

 

9. Global Market: By Application Segment Analysis

    9.1. Introduction

    9.2. Sales Volume & Revenue Analysis (2021-2030)

    9.3. Peripheral Vascular

       9.3.1.   Peripheral Vascularmarket, 2021-2030 (USD Million)

    9.4. Cardiovascular

       9.4.1.   Cardiovascularmarket, 2021-2030 (USD Million)

    9.5. Neurovascular

       9.5.1.   Neurovascularmarket, 2021-2030 (USD Million)

 

10. Global Market: Regional Outlook

10.1 North America

       10.1.1.  North America market, by By Type, 2021-2030 (USD Million)

       10.1.2.  North America market, by By End-User, 2021-2030 (USD Million)

       10.1.3.  North America market, by Application, 2021-2030 (USD Million)

       10.1.4.  North America market, by Country, 2021-2030 (USD Million)

    10.1.4.1. U.S.

           10.1.4.1.1.  U.S. market, by By Type, 2021-2030 (USD Million)

           10.1.4.1.2.  U.S. market, by By End-User, 2021-2030 (USD Million)

           10.1.4.1.3.  U.S. market, by Application, 2021-2030 (USD Million)

10.1.4.2.Canada

           10.1.4.2.1.  Canada market, by By Type, 2021-2030 (USD Million)

           10.1.4.2.2.  Canada market, by By End-User, 2021-2030 (USD Million)

           10.1.4.2.3.  Canada market, by Application, 2021-2030 (USD Million)

10.2. Europe

       10.2.1.  Europe market, by By Type, 2021-2030 (USD Million)

       10.2.2.  Europe market, by By End-User, 2021-2030 (USD Million)

       10.2.3.  Europe market, by Application, 2021-2030 (USD Million)

       10.2.4.  Europe market, by country, 2021-2030 (USD Million)

10.2.4.1  U.K.

           10.2.4.1.1.  U.K. market, by By Type, 2021-2030 (USD Million)

           10.2.4.1.2.  U.K. market, by By End-User, 2021-2030 (USD Million)

           10.2.4.1.3.  U.K. market, by Application, 2021-2030 (USD Million)

10.2.4.2.       Germany

           10.2.4.2.1.  Germany market, by By Type, 2021-2030 (USD Million)

           10.2.4.2.2.  Germany market, by By End-User, 2021-2030 (USD Million)

           10.2.4.2.3.  Germany market, by Application, 2021-2030 (USD Million)

10.2.4.3.       France

           10.2.4.3.1.  France market, by By Type, 2021-2030 (USD Million)

           10.2.4.3.2.  France market, by By End-User, 2021-2030 (USD Million)

           10.2.4.3.3.  France market, by Application, 2021-2030 (USD Million)

10.2.4.4.       Rest of Europe

           10.2.4.4.1.  Rest of Europe market, by By Type, 2021-2030 (USD Million)

           10.2.4.4.2.  Rest of Europe market, by By End-User, 2021-2030 (USD Million)

           10.2.4.4.3.  Rest of Europe market, by Application, 2021-2030 (USD Million)

    10.3.       Asia Pacific

       10.3.1.  Asia Pacific market, by By Type, 2021-2030 (USD Million)

       10.3.2.  Asia Pacific market, by By End-User, 2021-2030 (USD Million)

       10.3.3.  Asia Pacific market, by Application, 2021-2030 (USD Million)

       10.3.4.  Asia Pacific market, by country, 2021-2030 (USD Million)

10.3.4.1.       China

           10.3.4.1.1.  China market, by By Type, 2021-2030 (USD Million)

           10.3.4.1.2.  China market, by By End-User, 2021-2030 (USD Million)

           10.3.4.1.3.  China market, by Application, 2021-2030 (USD Million)

10.3.4.2.       India

           10.3.4.2.1.  India market, by By Type, 2021-2030 (USD Million)

           10.3.4.2.2.  India market, by By End-User, 2021-2030 (USD Million)

           10.3.4.2.3.  India market, by Application, 2021-2030 (USD Million)

10.3.4.3.       Japan

           10.3.4.3.1.  Japan market, by By Type, 2021-2030 (USD Million)

           10.3.4.3.2.  Japan market, by By End-User, 2021-2030 (USD Million)

           10.3.4.3.3.  Japan market, by Application, 2021-2030 (USD Million)

10.3.4.4.       South Korea

           10.3.4.4.1.  South Korea market, by By Type, 2021-2030 (USD Million)

           10.3.4.4.2.  South Korea market, by By End-User, 2021-2030 (USD Million)

           10.3.4.4.3.  South Korea market, by Application, 2021-2030 (USD Million)

10.3.4.5.       Rest of ASIA PACIFIC

           10.3.4.5.1.  Rest of ASIA PACIFIC market, by By Type, 2021-2030 (USD Million)

           10.3.4.5.2.  Rest of ASIA PACIFIC market, by By End-User, 2021-2030 (USD Million)

           10.3.4.5.3.  Rest of ASIA PACIFIC market, by Application, 2021-2030 (USD Million)

    10.4.       Latin America

       10.4.1.  Latin America market, by By Type, 2021-2030 (USD Million)

       10.4.2.  Latin America market, by By End-User, 2021-2030 (USD Million)

       10.4.3.  Latin America market, by Application, 2021-2030 (USD Million)

       10.4.4.  Latin America market, by country, 2021-2030 (USD Million)

10.4.4.1.       Brazil

           10.4.4.1.1.  Brazil market, by By Type, 2021-2030 (USD Million)

           10.4.4.1.2.  Brazil market, by By End-User, 2021-2030 (USD Million)

           10.4.4.1.3.  Brazil market, by Application, 2021-2030 (USD Million)

10.4.4.2.       Mexico

           10.4.4.2.1.  Mexico market, by By Type, 2021-2030 (USD Million)

           10.4.4.2.2.  Mexico market, by By End-User, 2021-2030 (USD Million)

           10.4.4.2.3.  Mexico market, by Application, 2021-2030 (USD Million)

           10.4.4.3.    Rest of the Latin America

           10.4.4.3.1.  Rest of the Latin America market, by By Type, 2021-2030 (USD Million)

           10.4.4.3.2.  Rest of the Latin America market, by By End-User, 2021-2030 (USD Million)

           10.4.4.3.3.  Rest of the Latin America market, by Application, 2021-2030 (USD Million)

    10.5.       LAMEA

       10.5.1.  LAMEA market, by By Type, 2021-2030 (USD Million)

       10.5.2.  LAMEA market, by By End-User, 2021-2030 (USD Million)

       10.5.3.  LAMEA market, by Application, 2021-2030 (USD Million)

       10.5.4.  LAMEA market, by Region, 2021-2030 (USD Million)

 

11. Competitive Landscape

11.1 Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation

       11.1.1.  Company overview

       11.1.2.  Financial performance

       11.1.3.  ProductPortfolio Analysis

       11.1.4.  Business Strategy & Recent Development

11.2. MEDTRONIC

       11.2.1.  Company overview

       11.2.2.  Financial performance

       11.2.3.  Product Portfolio Analysis

       11.2.4.  Business Strategy & Recent Development

11.3. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL)

       11.3.1.  Company overview

       11.3.2.  Financial performance

       11.3.3.  Product Portfolio Analysis

       11.3.4.  Business Strategy & Recent Development

11.4. KONINKLIJKE PHILIPS N.V.

       11.4.1.  Company overview

       11.4.2.  Financial performance

       11.4.3.  Product Portfolio Analysis

       11.4.4.  Business Strategy & Recent Development

11.5. AVINGER, INC.

       11.5.1.  Company overview

       11.5.2.  Financial performance

       11.5.3.  Product Portfolio Analysis

       11.5.4.  Business Strategy & Recent Development

11.6. Rex Medical

       11.6.1.  Company overview

       11.6.2.  Financial performance

       11.6.3.  Product Portfolio Analysis

       11.6.4.  Business Strategy & Recent Development

11.7. AngioDynamics

       11.7.1.  Company overview

       11.7.2.  Financial performance

       11.7.3.  Product Portfolio Analysis

       11.7.4.  Business Strategy & Recent Development

 

List of Tables (48 Tables)

TABLE 1.  MARKET, By Type, 2021-2030 (USD Million)

TABLE 2.  MARKET FOR Directional Atherectomy, BY REGION, 2021-2030 (USD Million)

TABLE 3.  MARKET FOR Rotational Atherectomy, BY REGION, 2021-2030 (USD Million)

TABLE 4.  MARKET FOR Orbital Atherectomy, BY REGION, 2021-2030 (USD Million)

TABLE 5. MARKET, By End-User, 2021-2030 (USD Million)

TABLE 6. MARKET FOR Hospitals and Surgical Centres, BY REGION, 2021-2030 (USD Million)

TABLE 7. MARKET FOR Ambulatory Care Centres, BY REGION, 2021-2030 (USD Million)

TABLE 8. MARKET FOR Other End Users, BY REGION, 2021-2030 (USD Million)

TABLE 9. MARKET FOR Food & Beverages, BY REGION, 2021-2030 (USD Million)

TABLE 10. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 11. MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 12. MARKET FOR Peripheral Vascular, BY REGION, 2021-2030 (USD Million)

TABLE 13. MARKET FOR Cardiovascular, BY REGION, 2021-2030 (USD Million)

TABLE 14. MARKET FOR Neurovascular, BY REGION, 2021-2030 (USD Million)

TABLE 15. MARKET FOR Quality Testing, BY REGION, 2021-2030 (USD Million)

TABLE 16. MARKET FOR Others, BY REGION, 2021-2030 (USD Million)

TABLE 17. MARKET FOR Battery Powered , BY REGION, 2021-2030 (USD Million)

TABLE 18. MARKET, BY REGION, 2021-2030 (USD Million)

TABLE 19. NORTH AMERICA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 20. NORTH AMERICA MARKET, By Type, 2021-2030 (USD Million)

TABLE 21. NORTH AMERICA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 22. NORTH AMERICA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 23. EUROPE MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 24. EUROPE MARKET, By Type, 2021-2030 (USD Million)

TABLE 25. EUROPE MARKET, By End-User, 2021-2030 (USD Million)

TABLE 26. EUROPE MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 27. ASIA-PACIFIC MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 28. ASIA-PACIFIC MARKET, By Type, 2021-2030 (USD Million)

TABLE 29. ASIA-PACIFIC MARKET, By End-User, 2021-2030 (USD Million)

TABLE 30. ASIA-PACIFIC MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 31. LALAMEA MARKET, BY COUNTRY, 2021-2030 (USD Million)

TABLE 32. LALAMEA MARKET, By Type, 2021-2030 (USD Million)

TABLE 33. LALAMEA MARKET, By End-User, 2021-2030 (USD Million)

TABLE 34. LALAMEA MARKET, BY APPLICATION, 2021-2030 (USD Million)

TABLE 35. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: COMPANY SNAPSHOT

TABLE 36. Koninklijke Philips N.V.ott LaboratoriesBoston Scientific Corporation: OPERATING SEGMENTS

TABLE 37. MEDTRONIC: COMPANY SNAPSHOT

TABLE 38. MEDTRONIC: OPERATING SEGMENTS

TABLE 39. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): COMPANY SNAPSHOT

TABLE 40. BECTON, DICKINSON AND COMPANY (BD INTERVENTIONAL): OPERATING SEGMENTS

TABLE 41. KONINKLIJKE PHILIPS N.V. : COMPANY SNAPSHOT

TABLE 42. KONINKLIJKE PHILIPS N.V. : OPERATING SEGMENTS

TABLE 43. AVINGER, INC.: COMPANY SNAPSHOT

TABLE 44. AVINGER, INC.: OPERATING SEGMENTS

TABLE 45. Rex Medical: COMPANY SNAPSHOT

TABLE 46. Rex Medical: OPERATING SEGMENTS

TABLE 47. AngioDynamics: COMPANY SNAPSHOT

TABLE 48. AngioDynamics: OPERATING SEGMENTS

 

List of Figures (22 Figures)

Figure 1 Market: Research Methodology Steps

Figure 2 Research Design

Figure 3 Breakdown of Primaries: Market

Figure 4 Research Methodology: Hypothesis Building

Figure 5 Market: Product-Based Estimation

Figure 6 Top 7 Companies with Highest No. Of Patent in Last 9 Years

Figure 7 No. Of Patents Granted Per Year, 2019–2020

Figure 8 Import Data for , By Country, 2016–2020 (USD Thousand)

Figure 9 Export Data for , By Country, 2016–2020 (USD Thousand)

Figure 10 Data Triangulation Methodology

Figure 11 Market, By End-User, 2019 vs. 2025 (USD Million)

Figure 12 Market Share, By Application, 2019 vs. 2025 (USD Million)

Figure 13 Market Share, By Type, 2019 vs. 2025 (USD Million)

Figure 14 Geographical Snapshot of the Market

Figure 15 Orbital Atherectomy to Witness Higher CAGR in the Market for Type Segment during Forecast Period.

Figure 16 Peripheral Vascular to Witness Higher CAGR in the Market for Application Segment during Forecast Period.

Figure 17 Hospitals and Surgical Centres to Witness Higher CAGR in the Market for End-User Segment during Forecast Period.

Figure 18 APAC Region Accounted for the Largest Share of the Market, By Regional Basis, in 2019

Figure 19 Market: Drivers, Restraints, Opportunities, and Challenges

Figure 20 North America: Market Snapshot

Figure 21 Asia Pacific: Market Snapshot

Figure 22 Vendor Dive: Evaluation Overview

Choose License Type


$4485
$6449
$8339
Buy Now
"Click to avail the latest sample copy of the report"
Request Sample
"Probe before placing the order"
Pre-Order Enquiry
"Let's optimize your ROI by furnishing the best price"
Request Discount
"Want to curate the report according to your business needs:"
Ask for Customization
Related Reports
Buy Now
Request Sample

Trust Online

  • paypal.png
  • wiretransfers

Follow Us

  • facebook
  • twitter
  • instagram
  • linkedin

Contact Us

  • US: +1-315-636-4233
  • UK: +44-162-237-0614
  • IN: +91-826-083-6500
  • info@strategicmarketresearch.com
  • Strategic Market Research
    26, Broadway Suite 934, New York , 10004

Quick Link

  • Why SMR
  • Research Methodology
  • Media Coverage
  • Join Our Team
  • Press Release
  • Blog

Customer Support

  • FAQs
  • Contact
  • Terms of Use
  • Privacy Policy
  • Disclaimer Policy
  • Return Policy
Copyright © 2022 Strategic Market Research All rights reserved.